Search research articles
Contact Us
Filters
Showing results (51-60 of 143) with videos related to
Page
of 15
Sort By:
Oncotarget
|
November 8, 2012
Recurrent targets of aberrant somatic hypermutation in lymphoma
Alireza Hadj Khodabakhshi, Ryan D Morin, Anthony P Fejes, et al.
Oncotarget
|
May 26, 2016
Genetic heterogeneity in primary and relapsed mantle cell lymphomas: Impact of recurrent CARD11 mutations
Chenglin Wu, Noel Fcc de Miranda, Longyun Chen, et al.
The Journal of Clinical Investigation
|
November 3, 2010
BCL6 repression of EP300 in human diffuse large B cell lymphoma cells provides a basis for rational combinatorial therapy
Leandro C Cerchietti, Katerina Hatzi, Eloisi Caldas-Lopes, et al.
Blood
|
June 9, 2016
Comprehensive characterization of programmed death ligand structural rearrangements in B-cell non-Hodgkin lymphomas
Lauren C Chong, David D W Twa, Anja Mottok, et al.
Leukemia & Lymphoma
|
January 4, 2018
The genomic landscape of two Burkitt lymphoma cases and derived cell lines: comparison between primary and relapse samples
Claudia M Wever, Dominique Geoffrion, Bruno M Grande, et al.
Cancer Immunology Research
|
December 29, 2025
The CCL17-CCR4 axis is critical for mutant STAT6-mediated microenvironmental remodelling and therapeutic resistance in Relapsed/Refractory Diffuse Large B-cell Lymphoma
Madelyn J Abraham, Cynthia Guilbert, Natascha Gagnon, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
March 20, 2019
In vitro analyses of suspected arrhythmogenic thin filament variants as a cause of sudden cardiac death in infants
Sanam Shafaattalab, Alison Yueh Li, Eric Lin, et al.
The Journal of Pathology
|
June 26, 2019
Integrative genomic analysis of matched primary and metastatic pediatric osteosarcoma
Gian Luca Negri, Bruno M Grande, Alberto Delaidelli, et al.
Leukemia
|
August 13, 2022
Molecular determinants of outcomes in relapsed or refractory mantle cell lymphoma treated with ibrutinib or temsirolimus in the MCL3001 (RAY) trial
Ciara L Freeman, Prasath Pararajalingam, Ling Jin, et al.
Blood
|
September 2, 2025
The Origin, Diagnosis, and Prognosis of Oligomannose-Type Diffuse Large B-Cell Lymphoma
Dylan James Tatterton, Maddy L Newby, Joel D Allen, et al.
Page
of 15
Search research articles
Search
Showing results (51-60 of 143) with videos related to
Sort By:
Page
of 15
Oncotarget
|
November 8, 2012
Recurrent targets of aberrant somatic hypermutation in lymphoma
Alireza Hadj Khodabakhshi, Ryan D Morin, Anthony P Fejes, et al.
Oncotarget
|
May 26, 2016
Genetic heterogeneity in primary and relapsed mantle cell lymphomas: Impact of recurrent CARD11 mutations
Chenglin Wu, Noel Fcc de Miranda, Longyun Chen, et al.
The Journal of Clinical Investigation
|
November 3, 2010
BCL6 repression of EP300 in human diffuse large B cell lymphoma cells provides a basis for rational combinatorial therapy
Leandro C Cerchietti, Katerina Hatzi, Eloisi Caldas-Lopes, et al.
Blood
|
June 9, 2016
Comprehensive characterization of programmed death ligand structural rearrangements in B-cell non-Hodgkin lymphomas
Lauren C Chong, David D W Twa, Anja Mottok, et al.
Leukemia & Lymphoma
|
January 4, 2018
The genomic landscape of two Burkitt lymphoma cases and derived cell lines: comparison between primary and relapse samples
Claudia M Wever, Dominique Geoffrion, Bruno M Grande, et al.
Cancer Immunology Research
|
December 29, 2025
The CCL17-CCR4 axis is critical for mutant STAT6-mediated microenvironmental remodelling and therapeutic resistance in Relapsed/Refractory Diffuse Large B-cell Lymphoma
Madelyn J Abraham, Cynthia Guilbert, Natascha Gagnon, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
March 20, 2019
In vitro analyses of suspected arrhythmogenic thin filament variants as a cause of sudden cardiac death in infants
Sanam Shafaattalab, Alison Yueh Li, Eric Lin, et al.
The Journal of Pathology
|
June 26, 2019
Integrative genomic analysis of matched primary and metastatic pediatric osteosarcoma
Gian Luca Negri, Bruno M Grande, Alberto Delaidelli, et al.
Leukemia
|
August 13, 2022
Molecular determinants of outcomes in relapsed or refractory mantle cell lymphoma treated with ibrutinib or temsirolimus in the MCL3001 (RAY) trial
Ciara L Freeman, Prasath Pararajalingam, Ling Jin, et al.
Blood
|
September 2, 2025
The Origin, Diagnosis, and Prognosis of Oligomannose-Type Diffuse Large B-Cell Lymphoma
Dylan James Tatterton, Maddy L Newby, Joel D Allen, et al.
Page
of 15